Clinical Trial Update: Phase 1/2a Study on Allogeneic Osteoblastic Cells Implantation in Delayed-Union Fractures [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2a study of allogeneic osteoblastic cell implantation in long bone delayed-union fractures has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Long Bone Delayed-union Fracture

Drugs mentioned

• Bone Therapeutics S.A. allogeneic osteoblastic cells (osteoblastic cells)

Snippet

Sponsor: Bone Therapeutics S.A | Conditions: Long Bone Delayed-Union Fracture | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2021-09-28